Growth Metrics

Axsome Therapeutics (AXSM) Change in Inventory (2022 - 2026)

Axsome Therapeutics' Change in Inventory history spans 5 years, with the latest figure at $3.1 million for Q1 2026.

  • On a quarterly basis, Change in Inventory rose 1149.0% to $3.1 million in Q1 2026 year-over-year; TTM through Mar 2026 was $13.5 million, a 2353.5% increase, with the full-year FY2025 number at $10.7 million, up 1532.8% from a year prior.
  • Change in Inventory hit $3.1 million in Q1 2026 for Axsome Therapeutics, down from $3.6 million in the prior quarter.
  • Over the last five years, Change in Inventory for AXSM hit a ceiling of $5.0 million in Q3 2025 and a floor of -$1.7 million in Q3 2023.
  • Historically, Change in Inventory has averaged $1.5 million across 5 years, with a median of $1.3 million in 2023.
  • Biggest five-year swings in Change in Inventory: crashed 681.82% in 2023 and later skyrocketed 1149.0% in 2026.
  • Tracing AXSM's Change in Inventory over 5 years: stood at $1.3 million in 2022, then skyrocketed by 269.74% to $4.9 million in 2023, then crashed by 76.9% to $1.1 million in 2024, then soared by 222.41% to $3.6 million in 2025, then dropped by 14.56% to $3.1 million in 2026.
  • Business Quant data shows Change in Inventory for AXSM at $3.1 million in Q1 2026, $3.6 million in Q4 2025, and $5.0 million in Q3 2025.